DIFFERENT STROMAL CELL-LINES SUPPORT LINEAGE-SELECTIVE DIFFERENTIATION OF THE MULTIPOTENTIAL BONE-MARROW STEM-CELL CLONE LYD9

被引:36
作者
LEE, KH
KINASHI, T
TOHYAMA, K
TASHIRO, K
FUNATO, N
HAMA, K
HONJO, T
机构
[1] KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN
[2] KYOTO UNIV,CTR MOLEC BIOL & GENET,KYOTO 606,JAPAN
[3] OHNO PHARMACEUT CO LTD,MINASE RES LAB,KYOTO 618,JAPAN
关键词
D O I
10.1084/jem.173.5.1257
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An interleukin 3-dependent multipotential stem cell clone, LyD9, has been shown to generate mature B lymphocytes, macrophages, and neutrophils by coculture with primary bone marrow stromal cells. We report here that coculture with the cloned stromal cell lines PA6 and ST2 can support differentiation of LyD9 cells predominantly into granulocyte/macrophage colony-stimulating factor (GM-CSF)- and granulocyte (G)-CSF-responsive cells, respectively. However, these stromal cell lines were unable to support lymphopoiesis of LyD9 cells. The GM-CSF-dependent line, L-GM, which was derived from LyD9 cells cocultured with PA6 stromal cells, could differentiate into macrophages and granulocytes in the presence of GM-CSF. The L-GM line can further differentiate predominantly into neutrophils by coculture with ST2 stromal cells. The G-CSF-dependent line, L-G, which was derived from LyD9 cells cocultured with ST2 stromal cells, differentiated into neutrophils in response to G-CSF. Although the stromal cell-supported differentiation of LyD9 cells required the direct contact between LyD9 and stromal cells, a small fraction of LyD9 cells that were pretreated with 5-azacytidine could differentiate into neutrophils and macrophages without direct contact with stromal cells. These results indicate that different stromal cell lines support lineage-selective differentiation of the LyD9 stem cell and that 5-azacytidine treatment can bypass the requirement of direct contact with stromal cells, albeit with a lower frequency.
引用
收藏
页码:1257 / 1266
页数:10
相关论文
共 34 条
[1]   F4-80, A MONOCLONAL-ANTIBODY DIRECTED SPECIFICALLY AGAINST THE MOUSE MACROPHAGE [J].
AUSTYN, JM ;
GORDON, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (10) :805-815
[2]  
BENTLEY SA, 1981, EXP HEMATOL, V9, P308
[3]   AZACYTIDINE-INDUCED REACTIVATION OF ADENOSINE-DEAMINASE IN A MURINE CYTOTOXIC T-CELL LINE [J].
CASTELLAZZI, M ;
VIELH, P ;
LONGACRE, S .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (09) :1081-1086
[4]   B220 - A B-CELL-SPECIFIC MEMBER OF THE T200 GLYCOPROTEIN FAMILY [J].
COFFMAN, RL ;
WEISSMAN, IL .
NATURE, 1981, 289 (5799) :681-683
[5]   FUNCTIONAL STRIATED-MUSCLE CELLS FROM NON-MYOBLAST PRECURSORS FOLLOWING 5-AZACYTIDINE TREATMENT [J].
CONSTANTINIDES, PG ;
JONES, PA ;
GEVERS, W .
NATURE, 1977, 267 (5609) :364-366
[6]   5-AZACYTIDINE IS ABLE TO INDUCE THE CONVERSION OF TERATOCARCINOMA-DERIVED MESENCHYMAL CELLS INTO EPITHELIAL-CELLS [J].
DARMON, M ;
NICOLAS, JF ;
LAMBLIN, D .
EMBO JOURNAL, 1984, 3 (05) :961-967
[7]   CONDITIONS CONTROLLING PROLIFERATION OF HEMATOPOIETIC STEM-CELLS INVITRO [J].
DEXTER, TM ;
ALLEN, TD ;
LAJTHA, LG .
JOURNAL OF CELLULAR PHYSIOLOGY, 1977, 91 (03) :335-344
[8]   GROWTH OF FACTOR-DEPENDENT HEMATOPOIETIC PRECURSOR CELL-LINES [J].
DEXTER, TM ;
GARLAND, J ;
SCOTT, D ;
SCOLNICK, E ;
METCALF, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (04) :1036-1047
[9]  
DEXTER TM, 1987, ANNU REV CELL BIOL, V3, P423
[10]  
HARA K, 1988, EXP HEMATOL, V16, P256